Global Bioenergies SA (EPA: ALGBE)
France
· Delayed Price · Currency is EUR 0.810
+0.031 (3.98%)
Nov 22, 2024, 5:35 PM CET
Global Bioenergies Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 0.49 | 3.25 | 0.7 | 0.1 | 0.06 | 0.12 | Upgrade
|
| Other Revenue | - | - | - | 0.73 | - | 0 | Upgrade
|
| Revenue | 0.49 | 3.25 | 0.7 | 0.83 | 0.06 | 0.12 | Upgrade
|
| Revenue Growth (YoY) | -86.39% | 365.83% | -16.15% | 1202.99% | -45.65% | -83.03% | Upgrade
|
| Cost of Revenue | 0.64 | 3.62 | -0.95 | 0.92 | 0.1 | 0.95 | Upgrade
|
| Gross Profit | -0.16 | -0.37 | 1.65 | -0.09 | -0.03 | -0.83 | Upgrade
|
| Selling, General & Admin | 9.58 | 10.69 | 13.79 | 14 | 12.9 | 12.62 | Upgrade
|
| Other Operating Expenses | -5.66 | -5.6 | -0.96 | -3 | -3.16 | -3.04 | Upgrade
|
| Operating Expenses | 8.51 | 9.34 | 14.84 | 13.26 | 13.26 | 13.19 | Upgrade
|
| Operating Income | -8.67 | -9.71 | -13.19 | -13.35 | -13.29 | -14.02 | Upgrade
|
| Interest Expense | -0.17 | -0.12 | -0.12 | -0.11 | -0.2 | -0.23 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | -0 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.4 | 0.23 | 0.01 | 0.01 | 0 | -1.7 | Upgrade
|
| EBT Excluding Unusual Items | -8.43 | -9.6 | -13.31 | -13.45 | -13.5 | -15.96 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.01 | -0 | 0.03 | -0.03 | 0.02 | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | 0.17 | Upgrade
|
| Other Unusual Items | -0.11 | -0.24 | -0.15 | -0 | 0.07 | -0 | Upgrade
|
| Pretax Income | -8.55 | -9.84 | -13.43 | -13.48 | -13.41 | -15.79 | Upgrade
|
| Income Tax Expense | -1.19 | -1.19 | -1.45 | -1.71 | -2.26 | -1.41 | Upgrade
|
| Net Income | -7.36 | -8.66 | -11.99 | -11.77 | -11.15 | -14.38 | Upgrade
|
| Net Income to Common | -7.36 | -8.66 | -11.99 | -11.77 | -11.15 | -14.38 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 15 | 15 | 10 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 15 | 15 | 10 | 9 | Upgrade
|
| Shares Change (YoY) | 11.98% | 20.37% | 0.54% | 47.08% | 16.24% | 71.96% | Upgrade
|
| EPS (Basic) | -0.40 | -0.48 | -0.80 | -0.79 | -1.10 | -1.65 | Upgrade
|
| EPS (Diluted) | -0.40 | -0.48 | -0.80 | -0.79 | -1.10 | -1.65 | Upgrade
|
| Free Cash Flow | -4.7 | -8.23 | -12.1 | -14.72 | -11.29 | -10.51 | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.46 | -0.81 | -0.99 | -1.11 | -1.21 | Upgrade
|
| Gross Margin | -32.07% | -11.44% | 236.49% | -11.06% | -54.73% | - | Upgrade
|
| Operating Margin | -1782.73% | -298.87% | -1891.17% | -1604.50% | -20823.10% | -11937.80% | Upgrade
|
| Profit Margin | -1514.50% | -266.41% | -1718.39% | -1415.19% | -17461.05% | -12243.17% | Upgrade
|
| Free Cash Flow Margin | -965.97% | -253.13% | -1734.85% | -1769.65% | -17683.01% | -8947.64% | Upgrade
|
| EBITDA | -5.74 | -8.19 | -12.45 | -11.99 | -10.02 | -10.41 | Upgrade
|
| EBITDA Margin | - | -252.03% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 2.93 | 1.52 | 0.74 | 1.35 | 3.28 | 3.61 | Upgrade
|
| EBIT | -8.67 | -9.71 | -13.19 | -13.35 | -13.29 | -14.02 | Upgrade
|
| EBIT Margin | - | -298.87% | - | - | - | - | Upgrade
|
| Revenue as Reported | 6.2 | 8.91 | 1.71 | 3.88 | 3.28 | 3.49 | Upgrade
|
| Advertising Expenses | - | 0.15 | 0.31 | 1.29 | 0.03 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.